Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Horizon Therapeutics (HZNP)
Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,632,118
  • Shares Outstanding, K 228,995
  • Annual Sales, $ 3,629 M
  • Annual Income, $ 521,480 K
  • 60-Month Beta 1.03
  • Price/Sales 7.34
  • Price/Cash Flow 16.49
  • Price/Book 5.01
Trade HZNP with:
  • Price/Earnings ttm 25.89
  • Earnings Per Share ttm 4.49
  • Most Recent Earnings $1.20 on 08/08/23
  • Latest Earnings Date 11/01/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 15.43%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate 1.22
  • Number of Estimates 4
  • High Estimate 1.46
  • Low Estimate 0.93
  • Prior Year 1.25
  • Growth Rate Est. (year over year) -2.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
114.75 +1.35%
on 09/11/23
116.38 -0.07%
on 10/05/23
+0.79 (+0.68%)
since 09/05/23
3-Month
98.80 +17.71%
on 08/03/23
116.38 -0.07%
on 10/05/23
+13.33 (+12.95%)
since 07/05/23
52-Week
60.03 +93.74%
on 10/13/22
116.38 -0.07%
on 10/05/23
+49.25 (+73.45%)
since 10/05/22

Most Recent Stories

More News
3 Growth Pharma Stocks to Guard Your Portfolio

The pharma industry is experiencing significant growth, fueled by rising demand for personalized medicines, a revolutionary wave of drug development and robust government support. Therefore, it could be...

BMY : 50.52 (-2.21%)
HZNP : 116.30 (+0.04%)
ZTS : 197.04 (-0.09%)
3 Pharma Stocks With Potential to Outperform Pfizer Inc. (PFE) in October

Pfizer (PFE) is grappling with financial difficulties and declining performance. Yet, with growing pharmaceutical demand and industry advancements, robust pharma stocks Zoetis (ZTS), Horizon Therapeutics...

HZNP : 116.30 (+0.04%)
NVS : 103.25 (-0.63%)
PFE : 27.18 (-2.09%)
ZTS : 197.04 (-0.09%)
3 Pharma Stocks Surpassing Johnson & Johnson (JNJ)

The pharmaceutical sector is anticipated to thrive as demand grows and technology advances. While Johnson & Johnson (JNJ) receives much attention from investors, I believe Horizon Therapeutics Public Limited...

AMGN : 286.37 (-0.97%)
HZNP : 116.30 (+0.04%)
JNJ : 160.79 (-0.65%)
NVS : 103.25 (-0.63%)
RDY : 77.09 (-0.64%)
3 Growth Stocks to Buy in September

As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings

AXP : 216.96 (+1.12%)
AMGN : 286.37 (-0.97%)
HZNP : 116.30 (+0.04%)
AAPL : 181.16 (-0.75%)
NFLX : 587.65 (+0.70%)
AMZN : 174.73 (-0.15%)
DIS : 107.68 (-0.06%)
3 Pharma Stocks for Value Investors

The aging global population and the growing demand for drugs and therapies to treat chronic diseases are boosting the long-term prospects of the pharmaceutical industry. Amid this backdrop, value investors...

AMGN : 286.37 (-0.97%)
GSK : 42.34 (+0.28%)
HZNP : 116.30 (+0.04%)
NBIX : 135.58 (+1.04%)
PPH : 90.41 (-0.20%)
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

/PRNewswire/ -- Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal Trade...

AMGN : 286.37 (-0.97%)
HZNP : 116.30 (+0.04%)
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

AMGN : 286.37 (-0.97%)
BMY : 50.52 (-2.21%)
LLY : 771.92 (+0.31%)
XLV : 147.10 (-0.51%)
HZNP : 116.30 (+0.04%)
JNJ : 160.79 (-0.65%)
MRK : 128.84 (-0.47%)
NVS : 103.25 (-0.63%)
NVO : 123.49 (+0.03%)
XPH : 45.24 (+0.04%)
ALPMY : 11.0300 (+0.36%)
Is This the Green Light Biotech Stocks Have Been Waiting For?

It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.

COMP : 3.32 (-0.30%)
AMGN : 286.37 (-0.97%)
HZNP : 116.30 (+0.04%)
Markets Today: Stock Climb and Bond Yields Fall as Interest Rate Concerns Ease

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.45%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.59%. Stock indexes this morning are moderately higher on some...

ESH24 : 5,080.50 (unch)
NQH24 : 17,965.50 (-0.06%)
MMM : 91.82 (-0.82%)
HZNP : 116.30 (+0.04%)
ZBH : 126.88 (-1.78%)
BBIO : 34.87 (+2.56%)
HE : 12.25 (-3.24%)
RPT : 12.83 (-2.51%)
BSX : 66.67 (-0.49%)
APPF : 239.19 (+1.22%)
CRWD : 321.03 (+3.06%)
NVCR : 14.90 (-2.10%)
Is Amgen Stock a Top Buy and Hold?

The biotech checks several important boxes for long-term shareholders.

AMGN : 286.37 (-0.97%)
HZNP : 116.30 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Horizon Therapeutics plc is a biopharmaceutical focused on making drugs in arthritis, pain, inflammatory and orphan diseases areas.

See More

Key Turning Points

3rd Resistance Point 116.49
2nd Resistance Point 116.43
1st Resistance Point 116.37
Last Price 116.30
1st Support Level 116.25
2nd Support Level 116.19
3rd Support Level 116.13

See More

52-Week High 116.38
Last Price 116.30
Fibonacci 61.8% 94.85
Fibonacci 50% 88.21
Fibonacci 38.2% 81.56
52-Week Low 60.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar